| NCT ID | NCT07653347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Respiratory Synctial Virus |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2026-01-15 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Respiratory Syncytial Virus (RSV) is a main global cause of respiratory illness and death in infants. Previous infant vaccine trials have failed to demonstrate protection. Moreover, RSV infection during early infancy, particularly in infants younger than 4 months of age, is associated with more severe disease, reduced immune protection, and an increased risk of developing childhood asthma. This study aim to investigate the immunological and long-term health effects of a first exposure to RSV early (\<4 months) versus late (\>6-9 months) in infancy.
Eligibility Criteria
Inclusion Criteria: Birthing parent/child pairs with a delivery date in April, May or June or September, October or November who delivered or are planning to deliver at BC Women's Hospital + Health Centre or a nearby, local hospital. Exclusion Criteria: Severe pregnancy-related complications or chronic medical conditions in the children making them automatically eligible to receiving RSV immunoprophylaxis in British Columbia (e.g. infants born prematurely \< 35 weeks of gestation, or with chronic medical conditions).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07653347 clinical trial?
This trial is open to participants of all sexes, up to 6 Months, studying Respiratory Synctial Virus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07653347 currently recruiting?
Yes, NCT07653347 is actively recruiting participants. Contact the research team at plavoie@bcchr.ca for enrollment information.
Where is the NCT07653347 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT07653347 clinical trial?
NCT07653347 is sponsored by University of British Columbia. The trial plans to enroll 300 participants.